Innovators in Drug Translation

Disulfican are pioneering the development of an expedited and cost-effective treatment for rare cancers


Disulfican lab photos


Disulfican are a dedicated team of researchers creating an affordable treatment to tackle rare, aggressive and terminal cancers such as Malignant Mesothelioma (MM). Disulfican have developed a modified version of disulfiram, an existing licensed drug, so that it can reach and attack cancer tumours without degrading in the body.

A Growing Problem

UK MM Cases 2020
UK MM Cases 2040
Median Survival
< months

People diagnosed with these diseases have very few treatment options and the hope is that our work will transform their prospects.

Prof. Weiguang Wang